Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Controlled release formulations of levodopa and uses thereof

Controlled release formulations of levodopa and uses thereof

US Patent 9901640 · Granted Feb 27, 2018

Estimated economic value: $28,837,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Muco-adhesive, controlled release formulation of levodopa and/or esters of levod2025
Muco-adhesive, controlled release formulation of levodopa and/or esters of levod2025
Extended local release of anti-CSFR1 antibodies2025
Muco-adhesive, controlled release formulation of levodopa and/or esters of levod2025
Muco-adhesive, controlled release formulation of levodopa and/or esters of levod2025
Combination decitabine and cedazuridine solid oral dosage forms2025
High concentration formulations of anti-CSF1 and anti-CSF1R antibodies2024
Muco-adhesive, controlled release formulations of levodopa and/or esters of levo2024
Muco-adhesive, controlled release formulation of levodopa and/or esters of levod2024
Muco-adhesive, controlled release formulation of levodopa and/or esters of levod2024
Muco-adhesive, controlled release formulations of levodopa and/or esters of levo2024
Stable protein solution formulation containing high concentration of an anti-VEG2024